Aytu BioPharma, Inc. (AYTU) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 67.33M | 76.24M | 81.11M | 79.18M | 72.51M | 63.05M | 60.74M | 61.89M | 71.13M | 71.37M | 70.6M | 72.83M |
| Cash & Short-Term Investments | 26.71M | 30.02M | 32.63M | 30.95M | 18.17M | 20.4M | 20.11M | 20.01M | 19.76M | 19.53M | 19.96M | 22.98M |
| Cash Only | 26.71M | 30.02M | 32.63M | 30.95M | 18.17M | 20.4M | 20.11M | 20.01M | 19.76M | 19.53M | 19.96M | 22.98M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 24.49M | 30.92M | 33.23M | 31.16M | 35.83M | 25.4M | 23.16M | 23.53M | 29.93M | 29.4M | 29.88M | 28.94M |
| Days Sales Outstanding | 200.91 | 194.58 | 213.24 | 201.36 | 149.32 | 137.71 | 129.57 | 135.29 | 192.47 | 145.46 | 151.86 | 93.24 |
| Inventory | 7.46M | 8.66M | 10.1M | 11.43M | 11.06M | 11.09M | 11.74M | 12.14M | 13.19M | 13M | 12.97M | 11.99M |
| Days Inventory Outstanding | 130.13 | 142.21 | 210.67 | 209.67 | 176.49 | 193.17 | 239.37 | 189.9 | 325.28 | 288.17 | 240.26 | 95.85 |
| Other Current Assets | 8.66M | 0 | 0 | 0 | 0 | 0 | 0 | 1.12M | 1M | 1.33M | 749K | 868K |
| Total Non-Current Assets | 44.36M | 45.76M | 43.88M | 45M | 51.69M | 53.17M | 55.09M | 56.97M | 57.73M | 59.88M | 62.29M | 65.01M |
| Property, Plant & Equipment | 1.32M | 1.44M | 1.51M | 1.59M | 1.66M | 1.69M | 1.92M | 1.52M | 2.76M | 3.26M | 4.18M | 3.87M |
| Fixed Asset Turnover | 8.99x | 10.27x | 8.95x | 9.31x | 11.01x | 8.98x | 9.64x | 8.39x | 4.66x | 5.04x | 4.43x | 7.44x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 42.49M | 43.58M | 41.43M | 42.2M | 48.71M | 49.96M | 51.2M | 52.45M | 54.08M | 55.71M | 57.34M | 58.97M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 556K | 738K | 939K | 1.2M | 1.32M | 1.52M | 1.97M | 2.23M | 889K | 907K | 772K | 792K |
| Total Assets | 111.69M | 122M | 124.99M | 124.18M | 124.2M | 116.23M | 115.83M | 118.86M | 128.86M | 131.25M | 132.89M | 137.84M |
| Asset Turnover | 0.11x | 0.12x | 0.11x | 0.12x | 0.15x | 0.14x | 0.14x | 0.15x | 0.11x | 0.14x | 0.13x | 0.22x |
| Asset Growth % | -10.07% | 4.97% | 7.91% | 4.48% | -3.62% | -11.45% | -12.84% | -13.77% | -12.47% | -7.2% | -11.41% | 0.16% |
| Total Current Liabilities | 59.97M | 65.56M | 65.99M | 63.06M | 70.71M | 64.05M | 61.25M | 62.23M | 83.69M | 64.19M | 65.46M | 69.02M |
| Accounts Payable | 13.21M | 14.26M | 12.34M | 10.6M | 12.04M | 11.7M | 13.51M | 10.31M | 10.47M | 10.47M | 14.47M | 13.48M |
| Days Payables Outstanding | 221.83 | 201.69 | 224.45 | 211.07 | 189.21 | 213.39 | 238.84 | 155.83 | 260.13 | 276.77 | 268.97 | 105.27 |
| Short-Term Debt | 12.47M | 11.13M | 16.73M | 10.92M | 11.88M | 5.87M | 6.13M | 4.96M | 16.7M | 1.03M | 1.28M | 8.74M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40.73M | 0 |
| Other Current Liabilities | 34.29M | 37.88M | 9.71M | 26.14M | 29M | 16.01M | 21.55M | 42.35M | 33.68M | 27.85M | 3.55M | 41.12M |
| Current Ratio | 1.12x | 1.16x | 1.23x | 1.26x | 1.03x | 0.98x | 0.99x | 0.99x | 0.85x | 1.11x | 1.08x | 1.06x |
| Quick Ratio | 1.00x | 1.03x | 1.08x | 1.07x | 0.87x | 0.81x | 0.80x | 0.80x | 0.69x | 0.91x | 0.88x | 0.88x |
| Cash Conversion Cycle | 109.21 | 135.1 | 199.46 | 199.96 | 136.59 | 117.5 | 130.1 | 169.36 | 257.62 | 156.87 | 123.15 | 83.83 |
| Total Non-Current Liabilities | 16.57M | 42.24M | 35.82M | 42.15M | 18.6M | 21.41M | 24.75M | 28.91M | 14.4M | 34.21M | 35.26M | 29.47M |
| Long-Term Debt | 9.55M | 10.97M | 10.45M | 10.89M | 9.54M | 9.98M | 10.43M | 10.88M | 5M | 14.98M | 14.84M | 20.86M |
| Capital Lease Obligations | 919K | 973K | 0 | 985K | 1M | 1.11M | 1.14M | 577K | 783K | 845K | 62K | 832K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 762K | 0 | 0 | 0 | 1.38M |
| Other Non-Current Liabilities | 6.11M | 30.29M | 25.38M | 30.27M | 8.06M | 10.32M | 13.18M | 16.7M | 8.61M | 18.39M | 20.35M | 6.4M |
| Total Liabilities | 76.55M | 107.8M | 101.82M | 105.21M | 89.3M | 85.46M | 86M | 91.14M | 98.09M | 98.4M | 100.72M | 98.48M |
| Total Debt | 22.94M | 23.07M | 27.18M | 22.94M | 22.52M | 17.14M | 18.18M | 16.42M | 22.5M | 18.26M | 16.24M | 30.43M |
| Net Debt | -3.78M | -6.95M | -5.45M | -8.02M | 4.35M | -3.26M | -1.92M | -3.59M | 2.74M | -1.27M | -3.72M | 7.44M |
| Debt / Equity | 0.65x | 1.62x | 1.17x | 1.21x | 0.65x | 0.56x | 0.61x | 0.59x | 0.73x | 0.56x | 0.50x | 0.77x |
| Debt / EBITDA | - | - | - | - | 6.03x | - | 36.59x | - | - | 3.70x | 16.64x | 13.32x |
| Net Debt / EBITDA | - | - | - | - | 1.16x | - | -3.87x | - | - | -0.26x | -3.81x | 3.26x |
| Interest Coverage | -9.32x | -17.90x | 4.81x | -25.63x | 5.24x | 1.35x | 2.51x | -1.65x | -0.41x | 2.11x | -4.82x | - |
| Total Equity | 35.14M | 14.2M | 23.17M | 18.97M | 34.9M | 30.77M | 29.83M | 27.72M | 30.78M | 32.85M | 32.17M | 39.36M |
| Equity Growth % | 0.7% | -53.84% | -22.31% | -31.57% | 13.39% | -6.36% | -7.28% | -29.58% | -24.77% | -28.3% | -40.33% | -11.17% |
| Book Value per Share | 3.34 | 1.41 | 1.19 | 2.79 | 4.25 | 3.63 | 3.28 | 5.00 | 5.57 | 5.95 | 5.87 | 9.69 |
| Total Shareholders' Equity | 35.14M | 14.2M | 23.17M | 18.97M | 34.9M | 30.77M | 29.83M | 27.72M | 30.78M | 32.85M | 32.17M | 39.36M |
| Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K |
| Retained Earnings | -347.77M | -342.15M | -331.57M | -333.54M | -313.72M | -317.71M | -318.5M | -319.97M | -315.36M | -312.47M | -312.25M | -304.13M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |